SmithKline drug wins change of status
Wednesday 07 July 1993
Glaxo does not expect to apply for non-prescription status for its rival drug, Zantac, until the end of 1994.
Tagamet, which also relieves symptoms of dyspepsia and hyperacidity, has been available on prescription in Britain since 1976.
Yesterday's decision by the Committee on Safety of Medicines brings the drug a crucial step closer to over- the-counter status.
The markets closed before news of the decision came through, but a favourable reaction is expected this morning. Analysts said the decision could indicate that Tagamet will win similar status in the US soon.
Recent figures from SmithKline estimated the total US market in over- the-counter drugs at pounds 6.5bn in 1992. The UK market was valued at pounds 550m.
SmithKline lodged its application for over-the-counter status for Tagamet in the US as long ago as 1989 and will have a meeting with the FDA advisory committee in September.
US approval is unlikely this year, although SmithKline is keen to win approval before Tagamet comes off US patent next May.
'Obviously the States is the real market to crack,' said Paul Woodhouse, an analyst at Smith New Court. 'These authorities tend to work independently, but if a European market gives it the thumbs-up they must think it bodes well.
'If Tagamet gets US approval such a product would generate several hundred million pounds' worth of revenue for the company.'
SmithKline believes Tagamet to be superior to existing over-the-counter antacids that neutralise acid in the stomach. Tagamet, whose active ingredient is cimetidine, reduces the amount of acid secreted in the first place, allowing the effect to last longer.
Zantac provided nearly half of Glaxo's pounds 1.4bn pre-tax profit for the year ended June 1992.
Presents unwrapped, turkey gobbled... it's time to relax
- 1 Shia LaBeouf claims he was raped during #IAMSORRY art installation performance
- 2 This letter from a reader explains why women can’t play football
- 3 'You should come to my house and eat cheeses with me': 4-year-old sends adorable love letter to girl at school
- 4 Scientists predict green energy revolution after incredible new graphene discoveries
- 5 Michael Buerk wishes he killed Jimmy Savile when he had the chance - by pushing him overboard a cruise ship
Sean Abbott: Messages of support flood in for bowler after death of Phil Hughes
Plebgate: Andrew Mitchell’s reputation in tatters as judge rules he used the word ‘pleb’
Dr Lam Hoe Yeoh: Voyeur doctor jailed for eight years after using network of hidden cameras to film patients, colleagues and friends on the toilet
Kim Jong-un 'in dire need of allies' within his own government as younger sister appointed to senior role
Scientists predict green energy revolution after incredible new graphene discoveries
Obama: The only people with the right to object to immigration are Native Americans
Ukip says babies born to immigrants in the UK should be classed as migrants – which would include Nigel Farage’s own children
The young are the new poor: Sharp increase in number of under-25s living in poverty, while over-65s are better off than ever
Tamir Rice: 12-year-old boy playing with fake gun dies after being shot by Ohio police
Ukip mocked after mistaking Westminster Cathedral – for a mosque
Sarah Vine criticises lesbian mother Jack Monroe: 'If she was unsure about her sexuality, she should have taken greater precautions'
iJobs Money & Business
£Attractive Package: Citifocus Ltd: Prestigious asset management house seeks a...
£Negotiable: Citifocus Ltd: This is a varied role focusing on the firm's mutua...
£90000 - £140000 per annum + benefits: h2 Recruit Ltd: Are you a high achievin...
£25000 - £37000 per annum + benefits: h2 Recruit Ltd: Are you seeking to furth...